Michal Preminger

Lucent Technologies used to design, develop and manufacture telecommunications systems, software and products. The company was headquartered in Welwyn Garden City, UK.

Anima Cell Metrology, Inc. engages in the development of novel technologies to monitor protein synthesis in living cells. The company was founded by Zeev Smilansky and is headquartered in Bernardsville, NJ.

Office of Technology Development (Office of Technology Development) is a venture capital subsidiary of Harvard University founded in 2007. The firm is headquartered in Cambridge, Massachusetts.

Bioarray Genetics, Inc. develops a patent-pending chemotherapy response assay to help guide physicians in the selection of the most effective treatments. It also develops proprietary predictive diagnostic tests, based on cancer genes (markers), to choose to the most efficacious treatment for cancer patients beforehand, rather than the trial and error approach currently used. The company was founded by Marcia Fournier and Katherine J. Martin in 2009 and is headquartered in Farmington, CT.

ElMindA Ltd. develops mapping and quantified neural communication for brain diag. It develops BNA technology platform, which allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain. The company was founded by Amir Geva in 2006 and is headquartered in Herzliya, Israel.

Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell.